Title : Targeting the autophagy promoted antitumor effect of T-DM1 on HER2-positive gastric cancer.

Pub. Date : 2021 Mar 17

PMID : 33731670






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Trastuzumab emtansine (T-DM1), an antibody-drug conjugate consisted of the HER2-targeted monoclonal antibody trastuzumab and the tubulin inhibitor emtansine, has shown potent therapeutic value in HER2-positive breast cancer (BC). Maytansine erb-b2 receptor tyrosine kinase 2 Homo sapiens
2 Trastuzumab emtansine (T-DM1), an antibody-drug conjugate consisted of the HER2-targeted monoclonal antibody trastuzumab and the tubulin inhibitor emtansine, has shown potent therapeutic value in HER2-positive breast cancer (BC). Maytansine erb-b2 receptor tyrosine kinase 2 Homo sapiens
3 Trastuzumab emtansine (T-DM1), an antibody-drug conjugate consisted of the HER2-targeted monoclonal antibody trastuzumab and the tubulin inhibitor emtansine, has shown potent therapeutic value in HER2-positive breast cancer (BC). Maytansine erb-b2 receptor tyrosine kinase 2 Homo sapiens